Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms CRBN-2-2-2-5-VHL |
Target |
Action degraders |
Mechanism CRBN degraders(Cereblon degraders) |
Therapeutic Areas- |
Active Indication- |
Inactive Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC46H59N7O11S |
InChIKeyWUEVGEJGJVGIOU-IINAPWRYSA-N |
CAS Registry- |





